Trastuzumab
Measuring Trastuzumab drug concentrations in patients being treated with Trastuzumab.
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Trastuzumab allows for reliable measurement of Trastuzumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Trastuzumab immediately before the next administration.
About Using Reagent
-
Sample Types
Serum, Plasma, Whole blood -
Reaction Time
10 mins -
Detection Range
3-150 μg/mL -
Intended Use
Quantitative determination of free Trastuzumab in human whole blood/serum/plasma
In Your Medical Field
AFIAS Trastuzumab measures Trastuzumab drug levels in patients' blood, using whole blood, serum, or plasma samples. This allows clinicians to obtain TDM results within just 10 minutes. It provides valuable insights into patients’ response to the treatment of Trastuzumab.